Leverage the captive audience our editorial team draws across our virtual and in-person events. Event sponsorships are key recognition opportunities alongside distinguished panelists who explore the biggest issues confronting the industry.
A special feature covering the latest in pharma innovation, manufacturing and development.
The cell & gene landscape is ripe with big promises backed by evolving tech, fresh talent with splashes of funding and M&A catching headlines as therapies roll forward. But how are the experts doing it in 2023? What are the biggest scientific advancements — and best strategies for investment, manufacturing and commercial access? Join us as we explore the field’s future — and examine past safety issues — with a series of sessions geared toward furthering cell & gene drug development.
What data are making the biggest waves at ASCO? Our slate of sessions include an expert roundtable, fireside and more. Join us as we analyze the most anticipated cancer conference of the year.
A series of presentations with our take on the most important biopharma R&D trends for the global audience convened during BIO.
The political issues circling the FDA this year could potentially ripple into biopharma on a scale that’s never been seen before. All eyes are on the FDA’s response to recent court rulings around the abortion pill mifepristone — and the potential effects on other approvals that might be questioned. What does the future look like, exactly? Join Endpoints’ Senior Editor Zachary Brennan in an expert panel to unpack what may come next. We’ll also touch on how the FDA is looking for new ways to spur more rare disease drug development with a fireside chat.
An Endpoints Day focused on drug commercialization, featuring a panel hosted by an Endpoints journalist with more sessions to be announced. This event will focus on trends in drug launches, marketing and sales.
Who are the women leading and influencing biopharma? Each year we seek out the up-and-comers moving the industry forward. Our in-depth profiles establish their stories into the fabric of an industry that isn’t changing fast enough to keep up with gender diversity.
An Endpoints Day focused on drug manufacturing, featuring a panel hosted by an Endpoints journalist with more sessions to be announced. We'll focus on the latest news and trends in drug supply chains, manufacturing developments and how the post-pandemic environment is affecting long-term capital expenditure planning.
Details coming soon
Charting the waters ahead for drug development in Europe — a day-long series of sessions on financing, R&D trends and regulatory issues that are central to the industry.
An Endpoints Day focused on clinical trials, featuring a panel session hosted by an Endpoints journalist and more. What are the latest trends in clinical trials? What regulatory curves are making the biggest waves? We’ll also take a look at how expectations from the industry and beyond are shifting the trial strategies of the future.
An Endpoints Day focused on drug discovery, featuring a panel session hosted by an Endpoints journalist with more sessions to be announced. This event will focus on research pipelines, emerging drug targets and the inflection point of research to development.
